Document Detail


Inducing ossification in an engineered 3D scaffold-free living cartilage template.
MedLine Citation:
PMID:  22925815     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Large and complex bone defects or voids cannot rely on natural bone healing process for recovery. They require natural or engineered grafts to facilitate osteo-progenitor cell recruitment and development. In this study, we have employed an in vitro macro-sized 3D cell-based platform for investigation and application of osteogenesis. The model is based on a porous construct made of engineered living cartilaginous tissue named living hyaline cartilaginous graft (LhCG). It is scaffold-free and is solely made up of living chondrocytes and their extra cellular matrix (ECM). To evaluate the efficiency of LhCG as a viable platform for bone formation, osteoblast and human mesenchymal stem cell (hMSC) were seeded respectively into LhCG constructs, establishing a co-culture system consisting of osteo-progenitors and chondrocytes. The results showed that LhCG could support both osteoblast and hMSC maturation and differentiation to the osteogenic lineage respectively. Successful osteogenesis is also observed after subcutaneous implantation in nude mice model suggesting that bone formation could be achieved both in vitro and in vivo. Additionally, with exposure to osteogenic medium, LhCG construct without any further cell seeding expressed similar levels of osteogenic phenotype markers as the ones with hMSC seeded on. It suggests the existence of an osteoprogenitor sub-population residing within LhCG chondrocytes. Hence, it is demonstrated that LhCG, as a cartilage template, could serve as a dynamic platform to support osteogenesis and its intrinsic phenotypic flexibility may also permit a wide range of applications for stem cell research and processing.
Authors:
Ting Ting Lau; Li Qi Priscilyn Lee; Bao Ngoc Vo; Kai Su; Dong-An Wang
Related Documents :
23741395 - Bcl11a controls flt3 expression in early hematopoietic progenitors and is required for ...
23625115 - Targeting oncogene expression to endothelial cells induces proliferation of the myelo-e...
23770775 - Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced t cells in myel...
24989835 - Leptin signaling is required for augmented therapeutic properties of mesenchymal stem c...
23741395 - Bcl11a controls flt3 expression in early hematopoietic progenitors and is required for ...
8418085 - Co-expression of cd4 and cd8 associated with elevated interleukin-4 in a cord t cell li...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-24
Journal Detail:
Title:  Biomaterials     Volume:  -     ISSN:  1878-5905     ISO Abbreviation:  Biomaterials     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100316     Medline TA:  Biomaterials     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Affiliation:
Division of Bioengineering, School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, N1.3-B2-13, Singapore 637457, Singapore.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter ...
Next Document:  Tyroserleutide-based gene vector for suppressing VEGF expression in cancer therapy.